TCT 672: Vascular healing of native coronary artery lesions following treatment with contemporary drug coated balloons: An optical coherence tomography sub-study from the SIROOP Registry

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker’s Bureau - Abbott Vascular; Abiomed; AstraZenca; Bayer AG; Daiichi-Sankyo/Elil Lilly and Company; SIS Medical; Boehringer Ingelheim; Novartis</li><li>Grant Support/Research Contract - Abbott Vascular; Vifor; SIS Medical; Biosensors; Cordis Corporation, a Johnson & Johnson company</li><li>Consultant Fee/Honoraria/Speaker's Bureau - Cordis Corporation, a Johnson & Johnson company; MedAlliance; NovoNordis; Amgen; Viatris; Sanofi</li></ul>